Your browser doesn't support javascript.
Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
Törüner, Murat; Kalkan, Ismail Hakki; Akyüz, Filiz; Tezel, Ahmet; Çelik, Aykut Ferhat.
  • Törüner M; Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
  • Kalkan IH; Department of Gastroenterology, TOBB University of Economics and Technology School of Medicine, Ankara, Turkey.
  • Akyüz F; Department of Gastroenterology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey.
  • Tezel A; Department of Gastroenterology, Trakya University School of Medicine, Edirne, Turkey.
  • Çelik AF; Department of Gastroenterology, Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey.
Turk J Gastroenterol ; 32(6): 488-492, 2021 06.
Article in English | MEDLINE | ID: covidwho-1362707
ABSTRACT
The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2, has resulted in high mortality and morbidity worldwide and is still a growing problem. Inflammatory bowel disease (IBD) is a chronic inflammatory disease for which a substantial number of patients are treated with immunosuppressive medications, either occasionally or long-term. Despite the accumulating evidence, there is still a lack of knowledge about the impact of COVID-19 on IBD patients, especially those who are under immunosuppressive treatment. Moreover, following the emergence of several COVID vaccines, there are concerns regarding vaccine effectiveness and possible side effects in such patients. In this context, we tried to briefly summarize the accumulating evidence and recommendations for the management of IBD in the context of the COVID-19 pandemic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Immunocompromised Host / COVID-19 / Immunosuppressive Agents Type of study: Diagnostic study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Turk J Gastroenterol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Tjg.2021.280721

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Immunocompromised Host / COVID-19 / Immunosuppressive Agents Type of study: Diagnostic study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Turk J Gastroenterol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Tjg.2021.280721